Literature DB >> 9185662

Use of glucagon for acute intravenous diltiazem toxicity.

N C Mahr1, A Valdes, G Lamas.   

Abstract

Intravenous diltiazem has become a preferred medication for treating supraventricular tachyarrhythmias in hospitalized patients. We present a case of inadvertent acute overdosage, its clinical effects, and successful treatment using intravenous glucagon.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9185662     DOI： 10.1016/s0002-9149(97)90000-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  5 in total

1.  Unexpected overdose with diltiazem: value of toxicological screening.

Authors:  P W Kamphuisen; M Karreman; M L R Tjin-A-Ton; H A Bosker; R van Nieuwenhuizen
Journal:  Neth Heart J       Date:  2001-06       Impact factor: 2.380

2.  Rapid reversal of vasoplegia with methylene blue in calcium channel blocker poisoning.

Authors:  Biplab K Saha; Alyssa Bonnier; Woon Chong
Journal:  Afr J Emerg Med       Date:  2020-07-10

3.  Management of lercanidipine overdose with hyperinsulinaemic euglycaemia therapy: case report.

Authors:  George Hadjipavlou; Aqib Hafeez; Ben Messer; Tom Hughes
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-01-20       Impact factor: 2.953

4.  Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults.

Authors:  Maude St-Onge; Kurt Anseeuw; Frank Lee Cantrell; Ian C Gilchrist; Philippe Hantson; Benoit Bailey; Valéry Lavergne; Sophie Gosselin; William Kerns; Martin Laliberté; Eric J Lavonas; David N Juurlink; John Muscedere; Chen-Chang Yang; Tasnim Sinuff; Michael Rieder; Bruno Mégarbane
Journal:  Crit Care Med       Date:  2017-03       Impact factor: 7.598

Review 5.  Treatment for calcium channel blocker poisoning: a systematic review.

Authors:  M St-Onge; P-A Dubé; S Gosselin; C Guimont; J Godwin; P M Archambault; J-M Chauny; A J Frenette; M Darveau; N Le Sage; J Poitras; J Provencher; D N Juurlink; R Blais
Journal:  Clin Toxicol (Phila)       Date:  2014-10-06       Impact factor: 4.467
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.